Reed Vaughn Tuckson - Apr 5, 2023 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
Director
Signature
/s/ Adam R. Craig, as attorney-in-fact for Reed V. Tuckson
Stock symbol
CTIC
Transactions as of
Apr 5, 2023
Transactions value $
$0
Form type
4
Date filed
4/7/2023, 06:17 PM
Previous filing
Mar 17, 2023
Next filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTIC Stock Option (right to buy) Award $0 +80K $0.00 80K Apr 5, 2023 Common Stock 80K $4.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2024 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event.